These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23531238)

  • 1. An ELISA for the quantitation of von Willebrand factor: osteoprotegerin complexes in plasma.
    Vinholt PJ; Overgaard M; Diederichsen AC; Mickley H; Poulsen TS; Sand NP; Nybo M; Rasmussen LM
    Thromb Res; 2013 May; 131(5):396-400. PubMed ID: 23531238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Siller-Matula J; Lang IM; Schoergenhofer C; Roest M; Jilma B
    Thromb Haemost; 2017 Aug; 117(9):1730-1738. PubMed ID: 28726980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of von Willebrand factor-FVIII binding activity in patients with suspected von Willebrand disease type 2N: application of an ELISA-based assay in a reference laboratory.
    Zhukov O; Popov J; Ramos R; Vause C; Ruden S; Sferruzza A; Dlott J; Sahud M
    Haemophilia; 2009 May; 15(3):788-96. PubMed ID: 19298374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of unfractionated and low-molecular-weight heparin on OPG, sRANKL, and von Willebrand factor concentrations during hemodialysis.
    Klejna K; Naumnik B; Koc-Żórawska E; Myśliwiec M
    Clin Appl Thromb Hemost; 2014 May; 20(4):433-41. PubMed ID: 23104956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoprotegerin (OPG) is localized to the Weibel-Palade bodies of human vascular endothelial cells and is physically associated with von Willebrand factor.
    Zannettino AC; Holding CA; Diamond P; Atkins GJ; Kostakis P; Farrugia A; Gamble J; To LB; Findlay DM; Haynes DR
    J Cell Physiol; 2005 Aug; 204(2):714-23. PubMed ID: 15799029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A sensitive ELISA for von Willebrand factor (vWf:Ag).
    Ingerslev J
    Scand J Clin Lab Invest; 1987 Apr; 47(2):143-9. PubMed ID: 3107116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of von Willebrand disorder and identification of qualitative von Willebrand factor defects. Direct comparison of commercial ELISA-based von Willebrand factor activity options.
    Favaloro EJ
    Am J Clin Pathol; 2000 Oct; 114(4):608-18. PubMed ID: 11026108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
    de Romeuf C; Mazurier C
    Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of active Von Willebrand factor are increased in patients with first ST-segment elevation myocardial infarction: a multicenter and multiethnic study.
    Rutten B; Maseri A; Cianflone D; Laricchia A; Cristell NA; Durante A; Spartera M; Ancona F; Limite L; Hu D; Li H; Uren NG; de Groot PG; Mannucci PM; Roest M
    Eur Heart J Acute Cardiovasc Care; 2015 Feb; 4(1):64-74. PubMed ID: 24833640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Application of collagen-binding assay for von Willebrand disease].
    Zhou J; Jia YQ; Jiang H; Yang YM; Deng CQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Jan; 35(1):126-9. PubMed ID: 14981837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use.
    Murdock PJ; Woodhams BJ; Matthews KB; Pasi KJ; Goodall AH
    Thromb Haemost; 1997 Oct; 78(4):1272-7. PubMed ID: 9364997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis.
    Veyradier A; Caron C; Ternisien C; Wolf M; Trossaert M; Fressinaud E; Goudemand J
    Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High circulating osteoprotegerin levels are associated with non-zero blood groups.
    Nagy EE; Varga-Fekete T; Puskas A; Kelemen P; Brassai Z; Szekeres-Csiki K; Gombos T; Csanyi MC; Harsfalvi J
    BMC Cardiovasc Disord; 2016 May; 16(1):106. PubMed ID: 27387019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
    Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
    Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the interaction between von Willebrand factor and osteoprotegerin.
    Shahbazi S; Lenting PJ; Fribourg C; Terraube V; Denis CV; Christophe OD
    J Thromb Haemost; 2007 Sep; 5(9):1956-62. PubMed ID: 17723135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of plasma von Willebrand factor concentration in patients with cerebrovascular disease].
    Wang Y
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Apr; 25(2):106-8, 127. PubMed ID: 1499407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive immunoassay for von Willebrand factor.
    Benson RE; Catalfamo JL; Brooks M; Dodds WJ
    J Immunoassay; 1991; 12(3):371-90. PubMed ID: 1939665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multispecies enzyme-linked immunosorbent assay for von Willebrand's factor.
    Benson RE; Catalfamo JL; Dodds WJ
    J Lab Clin Med; 1992 Apr; 119(4):420-7. PubMed ID: 1583394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
    van Genderen PJ; Boertjes RC; van Mourik JA
    Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.